| Title |
The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study
|
|---|---|
| Published in |
BMC Infectious Diseases, November 2011
|
| DOI | 10.1186/1471-2334-11-314 |
| Pubmed ID | |
| Authors |
Reed AC Siemieniuk, Dan B Gregson, M John Gill |
| Abstract |
The increasing use of highly active antiretroviral therapy (HAART) and pneumococcal immunization along with shifting community exposures may have altered the burden of Streptococcus pneumoniae disease in HIV-infected persons. We describe the burden and risk factors for pneumococcal disease in the modern era of HIV care and evaluate the use of a 23-valent pneumococcal polysaccharide vaccine (PPV-23). |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 112 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 19 | 17% |
| Researcher | 18 | 16% |
| Student > Postgraduate | 12 | 11% |
| Student > Bachelor | 12 | 11% |
| Student > Master | 11 | 10% |
| Other | 13 | 11% |
| Unknown | 29 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 31% |
| Agricultural and Biological Sciences | 17 | 15% |
| Biochemistry, Genetics and Molecular Biology | 7 | 6% |
| Immunology and Microbiology | 7 | 6% |
| Nursing and Health Professions | 6 | 5% |
| Other | 11 | 10% |
| Unknown | 31 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 October 2021.
All research outputs
#5,854,969
of 22,693,205 outputs
Outputs from BMC Infectious Diseases
#1,728
of 7,644 outputs
Outputs of similar age
#35,900
of 142,204 outputs
Outputs of similar age from BMC Infectious Diseases
#18
of 92 outputs
Altmetric has tracked 22,693,205 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 7,644 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 142,204 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.